erlotinib hydrochloride - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
ERLOTINIB SANDOZ erlotinib 25 mg tablet blister pack AUST R: 326623Active ingredients:
erlotinib hydrochloride
Dosage form:
Tablet, film coated
Sponsor:
Sandoz Pty Ltd
Phone:
1800726369
|
From
25 Jul 2025
to
12 Sep 2025
|
Shortage status:
Anticipated
Availability:
Available
Reason:
Unexpected increase in consumer demand
Management action:
The sponsor is working to expedite the next shipment.
|